Should Anacardium humile St. Hil be used as an antiulcer agent? A scientific approach to the traditional knowledge

dc.creatorLuiz-Ferreira, A
dc.creatorCola-Miranda, M
dc.creatorBarbastefano, V
dc.creatorHiruma-Lima, CA
dc.creatorVilegas, W
dc.creatorBrito, ARMS
dc.date2008
dc.dateAPR
dc.date2014-07-31T14:30:55Z
dc.date2015-11-26T16:27:40Z
dc.date2014-07-31T14:30:55Z
dc.date2015-11-26T16:27:40Z
dc.date.accessioned2018-03-28T23:08:37Z
dc.date.available2018-03-28T23:08:37Z
dc.identifierFitoterapia. Elsevier Science Bv, v. 79, n. 3, n. 207, n. 209, 2008.
dc.identifier0367-326X
dc.identifierWOS:000255385400014
dc.identifier10.1016/j.fitote.2007.11.006
dc.identifierhttp://www.repositorio.unicamp.br/jspui/handle/REPOSIP/75544
dc.identifierhttp://repositorio.unicamp.br/jspui/handle/REPOSIP/75544
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1269252
dc.descriptionThe crude methanolic extract (ME) obtained from the leaves of Anacardium humile was evaluated orally at doses of 250-500-1000 mg/kg on gastric lesion on ethanol and piroxicam induced gastric lesions in rodents. All the tested doses significantly inhibited gastric lesions by 56 to 100%. These results seems to support the traditional use of this species in the treatment of gastric diseases. (C) 2007 Elsevier B.V. All rights reserved.
dc.description79
dc.description3
dc.description207
dc.description209
dc.languageen
dc.publisherElsevier Science Bv
dc.publisherAmsterdam
dc.publisherHolanda
dc.relationFitoterapia
dc.relationFitoterapia
dc.rightsfechado
dc.rightshttp://www.elsevier.com/about/open-access/open-access-policies/article-posting-policy
dc.sourceWeb of Science
dc.subjectAnacardium humile
dc.subjectantiulcerogenic activity
dc.subjectgastric diseases
dc.subjectOccidentale
dc.subjectLesions
dc.subjectDrugs
dc.titleShould Anacardium humile St. Hil be used as an antiulcer agent? A scientific approach to the traditional knowledge
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución